AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 192 filers reported holding AGIOS PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $4,272 | -18.2% | 186 | 0.0% | 0.00% | – |
Q4 2022 | $5,223 | +4.5% | 186 | 0.0% | 0.00% | – |
Q3 2022 | $5,000 | +25.0% | 186 | 0.0% | 0.00% | – |
Q2 2022 | $4,000 | -20.0% | 186 | 0.0% | 0.00% | – |
Q1 2022 | $5,000 | -16.7% | 186 | 0.0% | 0.00% | – |
Q4 2021 | $6,000 | -33.3% | 186 | 0.0% | 0.00% | – |
Q3 2021 | $9,000 | -10.0% | 186 | 0.0% | 0.00% | – |
Q2 2021 | $10,000 | 0.0% | 186 | 0.0% | 0.00% | – |
Q1 2021 | $10,000 | +25.0% | 186 | +1.6% | 0.00% | – |
Q4 2020 | $8,000 | -90.2% | 183 | -89.3% | 0.00% | – |
Q4 2019 | $82,000 | -99.8% | 1,709 | -99.8% | 0.00% | -100.0% |
Q3 2019 | $35,113,000 | -34.8% | 1,083,694 | +0.4% | 0.04% | -29.8% |
Q2 2019 | $53,862,000 | -8.4% | 1,079,829 | +23.8% | 0.06% | -10.9% |
Q1 2019 | $58,822,000 | +47.9% | 872,225 | +1.1% | 0.06% | +23.1% |
Q4 2018 | $39,779,000 | -23.1% | 862,715 | +28.7% | 0.05% | -7.1% |
Q3 2018 | $51,705,000 | -2.0% | 670,443 | +7.0% | 0.06% | -1.8% |
Q2 2018 | $52,779,000 | +10.9% | 626,603 | +7.6% | 0.06% | +1.8% |
Q1 2018 | $47,607,000 | – | 582,141 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Ventures 2007 General Partner LLC | 1,930,369 | $118,428,000 | 83.56% |
Third Rock Ventures, LLC | 3,070,090 | $188,350,000 | 21.97% |
Opaleye Management Inc. | 113,500 | $6,963,225,000 | 5.43% |
BB BIOTECH AG | 1,890,521 | $115,983,000 | 4.72% |
Eventide Asset Management | 431,600 | $26,479,000 | 3.70% |
Atika Capital Management LLC | 54,000 | $3,313,000 | 2.55% |
Cormorant Asset Management, LP | 100,000 | $6,135,000 | 1.26% |
BRIDGER MANAGEMENT, LLC | 220,099 | $13,503,000 | 0.92% |
Ghost Tree Capital, LLC | 20,000 | $1,227,000 | 0.67% |
HAMILTON LANE ADVISORS LLC | 27,544 | $1,690,000 | 0.55% |